Seriderm - Serigen Mediproducts Private Limited

Products

SERIDERM®

Accelerated Wound Healing

Seriderm® is a non-adherent, absorbent wound dressing designed using silk protein for accelerated wound healing. It promotes faster and efficient healing of complex wounds such as diabetic foot ulcers, bed sores, and second-degree burns. In lab and animal studies, Seriderm® has outperformed leading global products in all wound healing parameters. It has also demonstrated superior wound healing in clinical settings.

Seriderm® is available as single-use disposable dressings sterilized by EO.

SERIDERM® Ag

Broad-Spectrum Protection, Reliable Healing

Seriderm® Ag is a complete wound healing solution that contains pure silk proteins with silver ions in the wound contact layer.

Seriderm® Ag offers accelerated wound healing and combats infections in a wide range of infected or high-risk wounds, including diabetic foot ulcers, bed sores, and second-degree burns.

SERIDERM® Border

Efficient Wound Healing, Without Disturbance

Seriderm® Border combines the superior wound healing benefits of silk protein with the secure durability of a silicone adhesive and conformable polyurethane film. This waterproof, adhesive wound dressing stays on for up to a week, offering sustained and superior healing for a wide range of wounds.

It is also available as Seriderm® Ag Border with the added antimicrobial action of Silver ions for infected or high-risk wounds.

SERIDERM® Post-Op

Uninterrupted Wound Closure Post-Surgery

Seriderm® Post-Op is a post-surgery wound dressing that offers undisturbed and accelerated healing for surgical wounds, with the benefits of 100% silk protein in the wound contact layer. This adhesive, waterproof wound dressing offers durability, comfort, and painless application and removal, while expediting healing of surgical wounds.

It is also available as Seriderm® Ag Post-Op with the added antimicrobial action of Silver ions for infected or high-risk surgical wounds.

Ravi Sarangpani

Consultant – Medical Devices

Accomplished medical device professional. Over 25 years in leadership roles in New Product Development, Quality & Regulatory Affairs, Marketing, Sales and Business Development.Proven track record of managing new product development from concept to market. Hands-on expertise in Risk Management, Design Verification & Validation, Excellent problem-solving ability. Strong background of interaction with KOLs, customers and trade channels in India and EMEA. Ravi Sarangpani has completed his Production Engineering in 1989 from K.J Somaiya College of Engineering, Mumbai University.

Consultant, Medical Devices

Self Employed – 2019 onwards
Consulting and Advisory Services for medical device and healthcare companies and start-ups. Mentor at Venture Center, Asia’s largest science-based incubator and Materials Science Center, Indian Institute of Science, Bengaluru. Faculty at AIM-Prime, training & guidance program for deep tech startups, initiative of Atal Innovation Mission and Niti Aayog implemented by Venture Center, Pune.

Adler Mediequip, A Smith & Nephew Company. Director NPD
2014 – 2019

Headed new product development for trauma, oncology and hip replacement for APAC region, 20-member team, USD 1m budget. Launched four new products in five years within budgets and targeted timelines. Implemented effective project management within a crossfunctional, multi-national, multi-locational project team. Developed and implemented design control procedure as per revised MDR that was adopted as model for implementation across sites.

Adler Mediequip. VP – Development & Quality Management
2010 – 2014

Headed Design, Quality and Regulatory Functions. Implemented structured D&D methodology, cross functional teams, ‘first time right’ culture for execution efficiency. Started in-house design verification including computational modeling and testing. Implemented GD&T across team and manufacturing organization. Launched 3 new products that contributed to successful clinical outcomes for 15000+ patients between 2012 – 2018. Designed innovative locking plate system for fractures that was granted patents in U.S, EU, Japan.

Sushrut Surgicals – A Sushrut-Adler Group Company
2001 – 2010 VP Marketing and Sales
1993 – 2000 Marketing Manager

Joined in start-up stage, grew business from $150k in 1993 to $3.6m by 2009. Established strong brand image and presence across India and 29 other countries. Developed KOL relationships that led to strong clinician driven product development.